• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

报告完整性和方法学质量的差距:一项对2023年1月发表的139项网络荟萃分析进行的元研究,采用PRISMA-NMA和AMSTAR-2。

Gaps in completeness of reporting and methodological quality: a metaresearch study of 139 network meta-analyses published in January 2023 using PRISMA-NMA and AMSTAR-2.

作者信息

Gianola Silvia, Guida Stefania, Ravot Gaia, Lunny Carole, Bargeri Silvia, Castellini Greta

机构信息

IRCCS Istituto Ortopedico Galeazzi, Unit of Clinical Epidemiology, Milan, Italy.

University of Milan, Milan, Italy.

出版信息

J Clin Epidemiol. 2025 Apr 9;183:111783. doi: 10.1016/j.jclinepi.2025.111783.

DOI:10.1016/j.jclinepi.2025.111783
PMID:40216340
Abstract

OBJECTIVES

Network meta-analysis (NMA) is a method for comparing multiple interventions simultaneously, combining evidence to estimate and rank their relative effectiveness and safety across a network of studies. This study evaluates (i) epidemiological and descriptive characteristics, (ii) reporting completeness, and (iii) methodological quality of NMAs.

STUDY DESIGN AND SETTING

In this metaresearch study (protocol at https://osf.io/pa6dz/), we searched PubMed for systematic reviews with NMAs indexed in January 2023. We extracted epidemiological and descriptive data, assessed reporting completeness using the modified Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for NMA, and evaluated the methodological quality using A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR-2).

RESULTS

Among the 139 NMAs, 77% were published in specialty journals (median journal impact factor [JIF] 4), and 52% originated from China. Reporting completeness and methodological quality were generally of a medium quality, with the median NMAs fulfilling 71% of the modified Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Network Meta-Analyses (PRISMA-NMA) and 63% of the AMSTAR-2 criteria. Items such as "network geometry" for modified PRISMA-NMA (15%) and "list of excluded studies" for AMSTAR-2 (12%) were frequently unfulfilled. Better reporting and methodological quality were associated with registered protocol, non-Chinese country, higher JIF, and larger author teams.

CONCLUSION

We highlight gaps in both reporting and methodological quality in NMAs. We recommend future authors to plan and conduct NMAs within a large author team that includes statistical experts and to strictly adhere to reporting and methodological quality standards. More attention should be given to the reporting of network geometry and documenting the list of excluded studies.

摘要

目的

网状Meta分析(NMA)是一种同时比较多种干预措施的方法,它整合证据以估计并排列它们在一系列研究中的相对有效性和安全性。本研究评估(i)流行病学和描述性特征,(ii)报告完整性,以及(iii)NMA的方法学质量。

研究设计与背景

在这项元研究(方案见https://osf.io/pa6dz/)中,我们在PubMed中检索了2023年1月索引的带有NMA的系统评价。我们提取了流行病学和描述性数据,使用针对NMA的修改后的系统评价和Meta分析的首选报告项目(PRISMA)扩展来评估报告完整性,并使用系统评价评估测量工具2(AMSTAR-2)来评估方法学质量。

结果

在139项NMA中,77%发表于专业期刊(期刊影响因子[JIF]中位数为4),52%来自中国。报告完整性和方法学质量总体中等,NMA中位数满足修改后的网状Meta分析的系统评价和Meta分析首选报告项目(PRISMA-NMA)的71%以及AMSTAR-2标准的63%。修改后的PRISMA-NMA中的“网络几何结构”(15%)和AMSTAR-2中的“排除研究列表”(12%)等项目经常未得到满足。更好的报告和方法学质量与注册方案、非中国国家、更高的JIF以及更大的作者团队相关。

结论

我们强调了NMA在报告和方法学质量方面的差距。我们建议未来的作者在一个包括统计专家的大型作者团队内计划和开展NMA,并严格遵守报告和方法学质量标准。应更多关注网络几何结构的报告以及记录排除研究的列表。

相似文献

1
Gaps in completeness of reporting and methodological quality: a metaresearch study of 139 network meta-analyses published in January 2023 using PRISMA-NMA and AMSTAR-2.报告完整性和方法学质量的差距:一项对2023年1月发表的139项网络荟萃分析进行的元研究,采用PRISMA-NMA和AMSTAR-2。
J Clin Epidemiol. 2025 Apr 9;183:111783. doi: 10.1016/j.jclinepi.2025.111783.
2
Do reporting guidelines have an impact? Empirical assessment of changes in reporting before and after the PRISMA extension statement for network meta-analysis.报告指南是否有影响?对 PRISMA 扩展声明前后网络荟萃分析报告变化的实证评估。
Syst Rev. 2021 Sep 10;10(1):246. doi: 10.1186/s13643-021-01780-9.
3
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
4
Does type of funding affect reporting in network meta-analysis? A scoping review of network meta-analyses.资金类型是否会影响网络荟萃分析的报告?网络荟萃分析的范围综述。
Syst Rev. 2023 May 6;12(1):81. doi: 10.1186/s13643-023-02235-z.
5
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.试验报告的统一标准(CONSORT)以及医学期刊上发表的随机对照试验(RCT)的报告完整性。
Cochrane Database Syst Rev. 2012 Nov 14;11(11):MR000030. doi: 10.1002/14651858.MR000030.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.
10
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.